JP2001526201A5 - - Google Patents

Download PDF

Info

Publication number
JP2001526201A5
JP2001526201A5 JP2000525069A JP2000525069A JP2001526201A5 JP 2001526201 A5 JP2001526201 A5 JP 2001526201A5 JP 2000525069 A JP2000525069 A JP 2000525069A JP 2000525069 A JP2000525069 A JP 2000525069A JP 2001526201 A5 JP2001526201 A5 JP 2001526201A5
Authority
JP
Japan
Prior art keywords
polyanionic
formula
weight
solid surface
microorganisms
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2000525069A
Other languages
English (en)
Other versions
JP4064627B2 (ja
JP2001526201A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP1998/007999 external-priority patent/WO1999032073A1/en
Publication of JP2001526201A publication Critical patent/JP2001526201A/ja
Publication of JP2001526201A5 publication Critical patent/JP2001526201A5/ja
Application granted granted Critical
Publication of JP4064627B2 publication Critical patent/JP4064627B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Description

【特許請求の範囲】
【請求項1】 アルカリホスファターゼを阻害するための、ポリアニオン性及びポリアニオン性に誘導された天然多糖類、又は誘導されていない天然多糖類の使用。
【請求項2】 (a)少なくとも1の直鎖状の分子脱水(molecularly dehydrated)されたポリホスファート塩0.01〜10重量%、及び
(b)β−グルカンから選択されるポリアニオン性天然多糖又はスルホキトサン、カルボキシメチルキトサン、ホスホキトサンから選択されるポリアニオン性に誘導された天然多糖0.0001〜5重量%
を含む、口腔用組成物。
【請求項3】 抗菌活性物質として、式(4):
【化4】
Figure 2001526201

〔式中、
Yは、クロロ又はブロモであり、
Zは、SO2H、NO2、又はC1-C4アルキルであり、
rは、0〜3であり、
oは、0〜3であり、
pは、0又は1であり、
mは、0又は1であり、そして
nは、0又は1である〕で示される化合物を更に含む、請求項2記載の組成物。
【請求項4】 細菌性プラークの予防又はその除去のための、微生物の固体表面への接着を予防するため、そして微生物を固体表面から脱着するための、請求項2又は3記載の口腔用組成物の使用。
JP2000525069A 1997-12-22 1998-12-09 アルカリホスファターゼを阻害するための、ポリアニオン性及びポリアニオン性に誘導された天然多糖類の使用 Expired - Fee Related JP4064627B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
EP97811012 1997-12-22
EP98810616 1998-07-02
EP97811012.0 1998-07-02
EP98810616.7 1998-07-02
PCT/EP1998/007999 WO1999032073A1 (en) 1997-12-22 1998-12-09 Use of polyanionic and polyanionically-derivatised natural polysaccharides for inhibiting alkaline phosphatase

Publications (3)

Publication Number Publication Date
JP2001526201A JP2001526201A (ja) 2001-12-18
JP2001526201A5 true JP2001526201A5 (ja) 2006-02-16
JP4064627B2 JP4064627B2 (ja) 2008-03-19

Family

ID=26148115

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2000525069A Expired - Fee Related JP4064627B2 (ja) 1997-12-22 1998-12-09 アルカリホスファターゼを阻害するための、ポリアニオン性及びポリアニオン性に誘導された天然多糖類の使用

Country Status (7)

Country Link
US (1) US6514950B1 (ja)
EP (1) EP1041960B1 (ja)
JP (1) JP4064627B2 (ja)
CN (1) CN1283100A (ja)
AU (1) AU2052699A (ja)
DE (1) DE69806638T2 (ja)
WO (1) WO1999032073A1 (ja)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19911055A1 (de) * 1999-03-12 2000-09-21 Cognis Deutschland Gmbh Verwendung von oberflächenaktiven Gemischen
US20030207945A1 (en) 2001-12-20 2003-11-06 Harper David Scott Non-halogenated phenyl substituted phenols, antimicrobial compositions containing the same, and methods of using the same
AU2002223958A1 (en) 2000-12-20 2002-07-01 Warner-Lambert Company Llc Non-halogenated phenoxy and/or benzyloxy phenols and antimicrobial compositions containing them
US7619008B2 (en) * 2004-11-12 2009-11-17 Kimberly-Clark Worldwide, Inc. Xylitol for treatment of vaginal infections
US20060217443A1 (en) * 2005-03-28 2006-09-28 Kimberly-Clark Worldwide, Inc. Method for preventing and/or treating vaginal and vulval infections
US7786176B2 (en) * 2005-07-29 2010-08-31 Kimberly-Clark Worldwide, Inc. Vaginal treatment composition containing xylitol
CN102516413B (zh) * 2011-12-09 2014-02-12 中国科学院海洋研究所 一种呋喃基α-氨基膦酸酯壳聚糖衍生物及其制备方法
WO2014098823A1 (en) * 2012-12-19 2014-06-26 Hill's Pet Nutrition, Inc. Animal food composition and method
WO2016201230A1 (en) 2015-06-10 2016-12-15 Rhodia Operations Phosphonated polysaccharides and gels and process for making same

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4515722A (en) 1982-03-30 1985-05-07 Merck & Co., Inc. Phosphatidyl inositol analogs useful as anti-inflammatory/analgesic agents
US4512968A (en) 1982-11-30 1985-04-23 Lion Corporation Oral compositions
US4627977A (en) 1985-09-13 1986-12-09 Colgate-Palmolive Company Anticalculus oral composition
SE512333C2 (sv) 1989-08-25 2000-02-28 Colgate Palmolive Co Antibakteriell oral komposition med plack- och tandstensbegränsande verkan
US5094844A (en) 1990-12-20 1992-03-10 Colgate-Palmolive Company Anticalculus oral composition
US5202111A (en) 1991-05-09 1993-04-13 Chesebrough-Pond's Usa Co., Division Of Conopco, Inc. Phosphorylated polyhydroxy compounds for tartar control
GB9403153D0 (en) 1994-02-18 1994-04-06 Ciba Geigy Ag Cosmetic compositions
SE518597C2 (sv) 1994-05-04 2002-10-29 Medicarb Ab Användning av kitosan i kombination med en sulfaterad, negativt laddad polysackarid för framställning av en dentalt verksam munhygienkomposition för behandling av parodontit, plaques och/eller karies
DE59504682D1 (de) 1994-11-24 1999-02-11 Ciba Geigy Ag Phosphonomethylierte Chitosane
DE69719834T2 (de) * 1996-04-24 2003-11-20 Pfizer Inc., New York Dentalwerkstoffe enthaltend Cyclodextrine und phenolische Verbindungen
US5869029A (en) 1996-06-21 1999-02-09 Hercules Incorporated Dispersible water-soluble or water-swellable polymers and process for making toothpastes containing them

Similar Documents

Publication Publication Date Title
JP2001526201A5 (ja)
JP2002332234A5 (ja)
MY151098A (en) Rapidly disintegrable solid preparation
JP2002060340A5 (ja)
AU2001276721A1 (en) Salts of benzimidazole compound and use thereof
CA2223172A1 (en) Methods and compositions for use against dental calculus in domestic animals
JP2002501057A5 (ja)
DE69309052D1 (de) Oral anzuwendende suspension bestehend aus stabilisiertem rockenpulver eines hydratisierten cephalosporins
EP1627642A3 (en) Zinc free insulin crystals for use in pulmonary compositions
CA2198099A1 (en) Use of tasteless, hydrolysed collagen and agent containing the same
NO308393B1 (no) Antibakterielt munnhygienepreparat
MY106337A (en) Detergent composition
CA2181605A1 (en) Liquid Formulation of 1,2-Benzisothiazolin-3-One
WO2000078275A3 (en) Antibacterial compositions
JP2002522501A5 (ja)
CA2256751A1 (fr) Comprime enrobe a base de maleate de trimebutine
CA2425715A1 (en) Use of polymers as filtering aids and/or stabilizers
UA83012C2 (ru) Кристаллическая форма натриевой соли 3-пиридил-1-гидроксиэтилиден-1,1-бисфосфоновой кислоты
JP2002519046A5 (ja)
JP2003508467A5 (ja)
AU1945495A (en) Acid addition salts of 2,3,4,5-tetrahydro-1h-3-benzazepine compounds
EP1420066A3 (en) Use of fullerene derivatives as DNA compaction agent
JP2003512511A5 (ja)
JP2002114686A5 (ja)
RU2001135821A (ru) Состав для полости рта, содержащий перлит